MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma

被引：12
|
作者：
Olarte, Irma [1 ]
Martinez, Adolfo [1 ]
Ramos-Penafiel, Christian [1 ]
Castellanos-Sinco, Humberto [1 ]
Zamora, Jorge [1 ]
Collazo-Jaloma, Juan [1 ]
Gutierrez, Mario [1 ]
Gutierrez-Kobeh, Laila [2 ]
Chavez-Olmos, Pedro [3 ]
Manzanilla, Hugo [4 ]
Garrido-Guerrero, Efrain [3 ]
Ordonez-Razo, Rosa M. [5 ]
Miranda, Enrique I. [1 ,6 ]
机构：
[1] Hosp Gen Mexico City, Serv Hematol, Lab Biol Mol, Mexico City 06726, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Sch Med, Mexico City, DF, Mexico
[3] CINVESTAV IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico
[4] Hosp Gen Mexico City, Serv Urol, Mexico City 06726, DF, Mexico
[5] IMSS, Ctr Med Siglo 21, Hosp Pediat, Unidad Invest Med Genet Humana, Mexico City, DF, Mexico
[6] Westhill Univ, Sch Med, Mexico City, DF, Mexico
来源：
HEMATOLOGY | 2011年 / 16卷 / 06期
关键词：
MAGE-A3; Expression; Prognostic; DLBCL; Lymphoma; NON-HODGKINS-LYMPHOMA; TISSUE MICROARRAY; GENE-EXPRESSION; CANCER; CHEMOTHERAPY; PREDICTION; CARCINOMA; SURVIVAL; MYELOMA; ANTIGEN;
D O I：
10.1179/102453311X13085644680384
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study evaluates the prognostic value of MAGE-A3 expression in 28 diffuse large B-cell lymphoma (DLBCL) patients. A significant association was observed between MAGE-A3 expressions, assessed by quantitative real-time RT-polymerase chain reaction (PCR), with advanced stages of disease (P<0.05). Elevated serum lactate dehydrogenase (LDH) levels and International Prognostic Index (IPI) score were significantly higher in MAGE-A3-positive patients (P=0.025 and P=0.004, respectively). Expression of MAGE-A3 was associated with poor response to treatment and a significantly shorter overall survival (P<0.001). Our data address new information in the association of MAGE-A3 expression and poor prognosis in DLBCL patients.
引用
收藏
页码：368 / 372
页数：5
相关论文
共 50 条
  • [31] MICRORNAS AS PROGNOSTIC BIOMARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA
    Larrabeiti, Etxebarria Ane
    Gandia, Blanca
    Gaafar, Ayman
    Arzuaga, Mendez Javier
    Martin, Arruti Maialen
    Guerra, Isabel
    Martin, Guerrero Idoia
    Lopez, Lopez Elixabet
    HAEMATOLOGICA, 2020, 105 : 379 - 379
  • [32] Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma
    Perry, Anamarija M.
    Mitrovic, Zdravko
    Chan, Wing C.
    CANCER CONTROL, 2012, 19 (03) : 214 - 226
  • [33] Outcome and prognostic factors in diffuse large B-cell lymphoma
    Mahajan, R.
    Yadav, B. S.
    Kumar, S.
    Gupta, A.
    Ghoshal, S.
    Sharma, S. C.
    Kumar, N.
    Kapoor, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [34] Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma
    Lin, Xiao-Ji
    Cai, Li-Meng
    Qian, Zi-Jun
    Wang, Chen-Yi
    Sun, Ni
    Sun, Xiao-Hai
    Huang, He
    Guo, Wen-Jian
    Lin, Hai-Yan
    Yao, Rong-Xin
    ONCOTARGETS AND THERAPY, 2017, 10 : 5129 - 5136
  • [35] Prognostic Significance of TSC2 Expression in Diffuse Large B-cell Lymphoma
    El Jabbour, Tony
    Dalvi, Siddhartha
    Sheehan, Christine E.
    Nazeer, Tipu
    Ross, Jeffrey
    LABORATORY INVESTIGATION, 2017, 97 : 347A - 347A
  • [36] Prognostic impact of C-REL expression in diffuse large B-cell lymphoma
    Curry C.V.
    Ewton A.A.
    Olsen R.J.
    Logan B.R.
    Preti H.A.
    Liu Y.-C.
    Perkins S.L.
    Chang C.-C.
    Journal of Hematopathology, 2009, 2 (1) : 20 - 26
  • [37] Osteopontin expression and its relationship with prognostic factors in diffuse large B-cell lymphoma
    Barranco, Gilberto
    Fernandez, Edith
    Rivas, Silvia
    Quezada, Roxana
    Nava, Dolores
    Aguilar, Jose
    Garcia, Abelardo
    Astudillo, Horacio
    Lome, Carmen
    Ruiz, Erika
    HEMATOLOGY REPORTS, 2019, 11 (03) : 55 - 58
  • [38] Prognostic significance of CDK1 expression in diffuse large B-Cell lymphoma
    Chen, Qiuni
    Xu, Lei
    Lu, Chuanyang
    Xue, Yujie
    Gong, Xue
    Shi, Yuye
    Wang, Chunling
    Yu, Liang
    BMC CANCER, 2025, 25 (01)
  • [39] Prognostic Significance of TSC2 Expression in Diffuse Large B-cell Lymphoma
    El Jabbour, Tony
    Dalvi, Siddhartha
    Sheehan, Christine E.
    Nazeer, Tipu
    Ross, Jeffrey
    MODERN PATHOLOGY, 2017, 30 : 347A - 347A
  • [40] Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma
    Mishina, Tatsuzo
    Miyoshi, Hiroaki
    Takeuchi, Mai
    Miyawaki, Kohta
    Nakashima, Kazutaka
    Yamada, Kyohei
    Moritsubo, Mayuko
    Inoue-Mitsuyama, Kanako
    Shimasaki, Yasumasa
    Imamoto, Teppei
    Kawamoto, Keisuke
    Furuta, Takuya
    Kohno, Kei
    Kato, Koji
    Akashi, Koichi
    Ohshima, Koichi
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
12345